Pediatric hematology and oncology in Iran

Mardawig Alebouyeh1

  • 1Department of Pediatric Hematology and Oncology, Shohada Medical Center, Shaheed Beheshti University of Medical Sciences, Tajrish-Tehran, Iran. alebouyehm@yahoo.com

Insights

Pediatric hematology and oncology services in Iran have expanded to meet the needs of children with blood disorders and cancers. Advances include improved care for beta-thalassemia and hemophilia, and standardized childhood cancer treatment.

Area of Science:

  • Pediatric Hematology and Oncology
  • Public Health Initiatives
  • Chronic Disease Management

Background:

  • Rapid expansion of Pediatric Hematology and Oncology (PHO) field necessitates optimized services.
  • Increasing demand for comprehensive medical care for children with blood diseases and malignancies.
  • Need to address prevalence and clinical importance of these conditions in Iran.

Purpose of the Study:

  • To outline the expansion and optimization of PHO services in Iran.
  • To detail the management strategies for major beta-thalassemia and hemophilia.
  • To describe the treatment protocols for childhood malignancies and available advanced therapies like Bone Marrow Transplantation (BMT).

Main Methods:

  • Expansion and optimization of PHO services by trained specialists and improved facilities.
  • Implementation of premarital screening and legal abortion for major beta-thalassemia.
  • Supervision and treatment of hemophiliacs through specialized care centers.
  • Regular screening for transfusion-related complications and viral diseases (HBV, HCV, HIV).
  • Adoption of international protocols for childhood malignancies treatment.
  • Public awareness campaigns and establishment of support groups and NGOs.
  • Foundation of the Iranian Society of Pediatric Hematology and Oncology (ISPHO).

Main Results:

  • Significant expansion and optimization of PHO services across Iran.
  • Standardized care for major beta-thalassemia (transfusion, chelation, screening) and hemophilia.
  • Comparable results in childhood malignancy treatment using international protocols.
  • Availability of Bone Marrow Transplantation (BMT) for selected cases.
  • Increased public awareness and establishment of patient support networks.
  • Consolidation of resources through the ISPHO.

Conclusions:

  • Collaborative studies and strategic planning are crucial for improving medical services, especially in underdeveloped regions.
  • Addressing national health challenges requires a scientifically based approach to service provision.
Abstract